Abstract:Shang Cai 1 , Qingqing Chen 2 , Yingying Xu 1 , Qianfeng Zhuang 3 , Shengjun Ji 2 1 Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China; 2 Department of Radiotherapy and Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China; 3 Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, China Submitted Jul 29, 2024. Accepted for publication Sep 10, 2024. Published online Oct 21, 2024. doi: 10.21037/tcr-2024-6 Retraction to: Transl Cancer Res 2020;9:1439-47. The article (1) "Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling" (doi: 10.21037/tcr.2020.01.27) published in the Vol 9, No 3 (March 31, 2020) issue of Translational Cancer Research has been retracted at the request of all the authors. During a comprehensive review of the experimental data and accompanying figures, an unintentional error was identified in the duplication of certain panels within Figure 7A , attributed to a lapse during the assembly of the visual materials. This mistake does not affect the interpretation or conclusion of this article, as the relevant experiments were repeated, and replaceable figures from these repeated experiments can be found. Nonetheless, the authors have decided to retract this article considering the rigor and accuracy required in scientific research. Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-2024-6/coif). The authors have no conflicts of interest to declare. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

RETRACTION: Radio-photothermal Therapy Mediated by a Single Compartment Nanoplatform Depletes Tumor Initiating Cells and Reduces Lung Metastasis in the Orthotopic 4T1 Breast Tumor Model (retraction of Vol 7, Pg 19438, 2015)

Retraction: Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model.

Retracted: Observation of the Curative Effect of Acupuncture for Tonifying Kidney and Removing Blood Stasis Combined with Radiofrequency Surgery in Patients with NSCLC and the Diagnostic Efficacy of Combined Detection of NTx, BGP, and CYFRA21-1 in the Occurrence of Bone Metastases

In situ Injection of pH- and Temperature-Sensitive Nanomaterials Increases Chemo-Photothermal Efficacy by Alleviating the Tumor Immunosuppressive Microenvironment [Retraction]

RETRACTION: Multi-Stimuli Nanocomposite Therapeutic: Docetaxel Targeted Delivery and Synergies in Treatment of Human Breast Cancer Tumor

Retraction: Cell Membrane Based Biomimetic Nanocomposites for Targeted Therapy of Drug Resistant EGFR-mutated Lung Cancer

Retracted: Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling

RETRACTION: An MSN-PEG-IP drug delivery system and IL13R2 as targeted therapy for glioma (Retraction of Vol 9, Pg 8970, 2017)

Retraction Note: Nuclear Factor of Activated T Cells 5 Maintained by Hotair Suppression of Mir-568 Upregulates S100 Calcium Binding Protein A4 to Promote Breast Cancer Metastasis

Retracted: The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma

Retracted: The Effect of Microwave Ablation Combined with Anti-PD-1 Monoclonal Antibody on T Cell Subsets and Long-Term Prognosis in Patients Suffering from Non-Small-Cell Lung Cancer

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Retraction]

Retraction: Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer

Retraction Note to: Injectable hydrogel encapsulating Cu2MnS2 nanoplates for photothermal therapy against breast cancer

RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3

Retracted: Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer

Retraction: Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling

Retracted: Application of Nanoparticles in Diagnosis and Treatment of Pancreatic Cancer

Retracted: Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma

[Retracted] Propofol exhibits a tumor‐suppressive effect and regulates cell viability, migration and invasion in bladder carcinoma by targeting the microRNA‐10b/HOXD10 signaling pathway

Retracted: lncRNA NUTM2A-AS1 Targets the SRSF1/Trim37 Signaling Pathway to Promote the Proliferation and Invasion of Breast Cancer